S. Avrameas, Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton, Immunol Today, vol.12, issue.5, pp.154-163, 1991.

H. Kohler, J. Bayry, A. Nicoletti, and S. V. Kaveri, Natural autoantibodies as tools to predict the outcome of immune response?, Scand J Immunol, vol.58, issue.3, pp.285-294, 2003.

S. R. Elluru, J. Vani, S. Delignat, M. F. Bloch, S. Lacroix-desmazes et al., Modulation of human dendritic cell maturation and function by natural IgG antibodies, Autoimmun Rev, vol.7, issue.6, pp.487-90, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-02455609

S. V. Kaveri, G. J. Silverman, and J. Bayry, Natural IgM in immune equilibrium and harnessing their therapeutic potential, J Immunol, vol.188, issue.3, pp.939-984, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02455557

S. R. Elluru, S. V. Kaveri, and J. Bayry, The protective role of immunoglobulins in fungal infections and inflammation, Semin Immunopathol, vol.37, issue.2, pp.187-97, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01103153

A. F. Cunningham, A. Flores-langarica, S. Bobat, D. Medina, C. C. Cook et al., B1b cells recognize protective antigens after natural infection and vaccination, Front Immunol, vol.5, p.535, 2014.

C. L. Sidman, L. D. Shultz, R. R. Hardy, K. Hayakawa, and L. A. Herzenberg, Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice, Science, vol.232, issue.4756, pp.1423-1428, 1986.

N. Baumgarth, The double life of a B-1 cell: self-reactivity selects for protective effector functions, Nat Rev Immunol, vol.11, issue.1, pp.34-46, 2011.

D. O. Griffin, N. E. Holodick, and T. L. Rothstein, Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70, J Exp Med, vol.208, issue.1, pp.67-80, 2011.

J. Vani, S. Elluru, V. S. Negi, S. Lacroix-desmazes, M. D. Kazatchkine et al., Role of natural antibodies in immune homeostasis: IVIg perspective, Autoimmun Rev, vol.7, issue.6, pp.440-444, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-02455610

M. H. Ravindranath, P. I. Terasaki, T. Pham, V. Jucaud, and S. Kawakita, Therapeutic preparations of IVIg contain naturally occurring anti-HLA-E antibodies that react with HLA-Ia (HLA-A/-B/-Cw) alleles, Blood, vol.121, issue.11, pp.2013-2041, 2013.

H. Bouhlal, D. Martinvalet, J. L. Teillaud, C. Fridman, M. D. Kazatchkine et al., Natural autoantibodies to Fcgamma receptors in intravenous immunoglobulins, J Clin Immunol, issue.1, pp.4-11, 2014.

E. W. Gelfand, Intravenous immune globulin in autoimmune and inflammatory diseases, N Engl J Med, vol.367, issue.21, pp.2015-2040, 2012.

J. Bayry, H. P. Hartung, and S. V. Kaveri, IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties, Trends Pharmacol Sci, vol.36, issue.7, pp.419-440, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01155485

L. Gilardin, J. Bayry, and S. V. Kaveri, Intravenous immunoglobulin as clinical immune-modulating therapy, CMAJ, vol.187, issue.4, pp.257-64, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02455495

L. Cantarini, D. Rigante, A. Vitale, S. Napodano, L. I. Sakkas et al., Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future, Immunol Res, issue.3, pp.326-363, 2015.

J. D. Lunemann, F. Nimmerjahn, and M. C. Dalakas, Intravenous immunoglobulin in neurology -mode of action and clinical efficacy, Nat Rev Neurol, vol.11, issue.2, pp.80-89, 2015.

C. Mauri and A. Bosma, Immune regulatory function of B cells, Annu Rev Immunol, vol.30, pp.221-262, 2012.

M. S. Maddur, S. V. Kaveri, and J. Bayry, Regulation of human dendritic cells by B cells depends on the signals they receive, Blood, vol.119, issue.16, pp.3863-3867, 2012.

A. Morva, S. Lemoine, A. Achour, J. O. Pers, P. Youinou et al., Maturation and function of human dendritic cells are regulated by B lymphocytes, Blood, vol.119, pp.106-120, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00771106

M. S. Maddur, M. Sharma, P. Hegde, E. Stephen-victor, B. Pulendran et al., Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand, Nat Commun, vol.5, p.4092, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02455506

V. Moulin, F. Andris, K. Thielemans, C. Maliszewski, J. Urbain et al., B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation, J Exp Med, vol.192, issue.4, pp.475-82, 2000.

N. K. Jerne, Towards a network theory of the immune system, Ann Immunol, vol.125, pp.373-89, 1974.

J. Oudin,

, Ann Immunol (Paris), vol.125, pp.309-346, 1974.

P. A. Cazenave and J. Oudin, the serum of rabbits immunized against human fibrinogen

N. K. Jerne, J. Roland, and P. A. Cazenave, Recurrent idiotopes and internal images, EMBO J, vol.1, issue.2, pp.243-250, 1982.

J. H. Huang, R. E. Ward, and H. Kohler, Idiotope antigens (Ab2 alpha and Ab2 beta) can induce in vitro B cell proliferation and antibody production, J Immunol, vol.137, issue.3, pp.770-776, 1986.

H. Kohler, M. Mcnamara, and R. E. Ward, Idiotypes as internal antigens, Prog Clin Biol Res, vol.172, pp.343-53, 1985.

S. Muller, H. T. Wang, S. V. Kaveri, S. Chattopadhyay, and H. Kohler, Generation and specificity of monoclonal anti-idiotypic antibodies against human HIVspecific antibodies. I. Cross-reacting idiotopes are expressed in subpopulations of HIV-infected individuals, J Immunol, vol.147, issue.3, pp.933-974, 1991.

M. S. Parsons, S. Muller, H. Kohler, M. D. Grant, and N. F. Bernard, On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?, Hum Vaccin Immunother, vol.9, issue.7, pp.1532-1540, 2013.

J. Fung and H. Kohler, Etlinger HM, Heusser CH. T15 dominance in BALB/c mice is not controlled by environmental factors, J Exp Med, vol.152, issue.5, pp.1988-91, 1980.

R. Halpern, S. V. Kaveri, and H. Kohler, Human anti-phosphorylcholine antibodies share idiotopes and are self-binding, J Clin Invest, vol.88, issue.2, pp.476-82, 1991.

S. V. Kaveri, R. Halpern, C. Y. Kang, and H. Kohler, Self-binding antibodies (autobodies) form specific complexes in solution, J Immunol, vol.145, issue.8, pp.2533-2541, 1990.

C. Y. Kang, T. K. Brunck, T. Kieber-emmons, J. E. Blalock, and H. Kohler, Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide, Science, vol.240, issue.4855, pp.1034-1040, 1988.

C. Y. Kang, H. L. Cheng, S. Rudikoff, and H. Kohler, Idiotypic self binding of a dominant germline idiotype (T15), J Exp Med, vol.165, issue.5, pp.1332-1375, 1987.

C. Y. Kang and H. Kohler, Immunoglobulin with complementary paratope and idiotope, J Exp Med, vol.163, issue.4, pp.787-96, 1986.

H. Kohler, Discovery of homophilic antibodies as novel drugs, Curr Trends Immunol, vol.10, pp.113-121, 2009.

S. V. Kaveri, R. Halpern, C. Y. Kang, and H. Kohler, Antibodies of different specificities are self-binding: implication for antibody diversity, Mol Immunol, vol.28, issue.7, pp.773-781, 1991.

M. Russ, D. Lou, and H. Kohler, Photo-activated affinity-site cross-linking of antibodies using tryptophan containing peptides, J Immunol Methods, vol.304, issue.1-2, pp.100-106, 2005.

S. V. Kaveri, C. Y. Kang, and H. Kohler, Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locus, J Immunol, vol.145, issue.12, pp.4207-4220, 1990.

D. E. Briles, C. Forman, S. Hudak, and J. L. Claflin, The effects of idiotype on the ability of IgG1 anti-phosphorylcholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae, Eur J Immunol, vol.14, issue.11, 1984.

P. X. Shaw, S. Horkko, M. K. Chang, L. K. Curtiss, W. Palinski et al., Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity, J Clin Invest, issue.12, pp.1731-1771, 2000.

G. Caligiuri, J. Khallou-laschet, M. Vandaele, A. T. Gaston, S. Delignat et al., Phosphorylcholine-targeting immunization reduces atherosclerosis, J Am Coll Cardiol, vol.50, issue.6, pp.540-546, 2007.

M. G. Bingaman, G. D. Basu, T. C. Golding, S. K. Chong, A. J. Lassen et al., The autophilic anti-CD20 antibody DXL625 displays enhanced potency due to lipid raft-dependent induction of apoptosis, Anticancer Drugs, vol.21, issue.5, pp.532-574, 2010.

H. Kohler, Homophilic antibodies as immunotherapeutics, Immunotherapy, vol.5, issue.3, pp.235-281, 2013.

P. X. Shaw, C. S. Goodyear, M. K. Chang, J. L. Witztum, and G. J. Silverman, The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells, J Immunol, vol.170, issue.12, pp.6151-6158, 2003.

G. J. Silverman, Targeting of B cells in SLE: rationale and therapeutic opportunities. Bull NYU Hosp Jt Dis, vol.64, pp.51-57, 2006.

F. Porcheray, J. W. Fraser, B. Gao, A. Mccoll, J. Devito et al., Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement, Am J Transplant, vol.13, issue.10, pp.2590-600, 2013.

M. H. Ravindranath, P. I. Terasaki, C. Y. Maehara, V. Jucaud, S. Kawakita et al., Immunoglobulin (Ig)G purified from human sera mirrors intravenous Ig human leucocyte antigen (HLA) reactivity and recognizes one's own HLA types, but may be masked by Fab complementarity-determining region peptide in the native sera, Clin Exp Immunol, vol.179, issue.2, pp.309-337, 2015.

M. Binder, F. Muller, M. Frick, C. Wehr, F. Simon et al., CLL B-cell receptors can recognize themselves: alternative epitopes and structural clues for autostimulatory mechanisms in CLL, Blood, vol.121, issue.1, pp.239-280, 2013.

M. Duhren-von-minden, R. Ubelhart, D. Schneider, T. Wossning, M. P. Bach et al., Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling, Nature, vol.489, issue.7415, pp.309-321, 2012.

A. J. Bryan and H. Kohler, Physical and biological properties of homophilic therapeutic antibodies, Cancer Immunol Immunother, vol.60, issue.4, pp.507-521, 2011.

H. Kohler and A. J. Bryan, Paradoxical concentration effect of a homodimerizing antibody against a human non-small cell lung cancer cell line, Cancer Immunol Immunother, vol.58, issue.5, pp.749-58, 2009.

C. A. Bona, C. Y. Kang, H. Kohler, and M. Monestier, Epibody: the image of the network created by a single antibody, Immunol Rev, vol.90, pp.115-142, 1986.

J. Urbain, N. Tasiaux, R. Leuwenkroon, A. Van-acker, and B. Mariame, Sharing of idiotypic specificities between different antibody populations from an individual rabbit, Eur J Immunol, vol.5, issue.8, pp.570-575, 1975.

Q. L. Wang, H. T. Wang, E. Blalock, S. Muller, and H. Kohler, Identification of an idiotypic peptide recognized by autoantibodies in human immunodeficiency virus-1-infected individuals, J Clin Invest, vol.96, issue.2, pp.775-80, 1995.

S. Muller, D. H. Margolin, P. L. Nara, W. G. Alvord, and H. Kohler, Stimulation of HIV-1-neutralizing antibodies in simian HIV-IIIB-infected macaques, Proc Natl Acad Sci U S A, vol.95, issue.1, pp.276-81, 1998.

S. Wallick, J. L. Claflin, and D. E. Briles, Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate, J Immunol, vol.130, issue.6, pp.2871-2876, 1983.

H. Wang, S. Muller, S. Zolla-pazner, and H. Kohler, Human monoclonal and polyclonal anti-human immunodeficiency virus-1 antibodies share a common clonotypic specificity, Eur J Immunol, vol.22, issue.7, pp.1749-55, 1992.

M. D. Grant, Antibody convergence along a common idiotypic axis in immunodeficiency virus and hepatitis C virus infections, J Med Virol, vol.66, issue.1, pp.13-21, 2002.

M. S. Parsons, D. Rouleau, J. P. Routy, R. Leblanc, M. D. Grant et al., Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire, AIDS, vol.25, issue.10, pp.1249-64, 2011.

S. Gonen, F. Dimaio, T. Gonen, and D. Baker, Design of ordered two-dimensional arrays mediated by noncovalent protein-protein interfaces, Science, vol.348, issue.6241, pp.1365-1373, 2015.

D. Holmberg, S. Forsgren, F. Ivars, and A. Coutinho, Reactions among IgM antibodies derived from normal, neonatal mice, Eur J Immunol, vol.14, issue.5, pp.435-476, 1984.

H. Kohler, Novel vaccine concept based on back-boost effect in viral infection, Vaccine, vol.33, issue.29, pp.3274-3279, 2015.

J. G. Jardine, T. Ota, D. Sok, M. Pauthner, D. W. Kulp et al., HIV-1 Vaccines. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen, Science, vol.349, issue.6244, pp.156-61, 2015.